Similarly, melanoregulin (MREG) downregulates the phosphatidylinositol 3 kinase (PI3K)/Akt-mTOR signaling pathway and simultaneously inhibits the invasion and proliferation of cancer cells (Meng et al., 2017). The gene discussed is AKT1; the disease is cancer.